Bellerophon Therapeutics, Inc.: cash_and_restricted_cash

Value{"amount": 13240000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"}
Period (as of 2019-09-30)
Statuscurrent
EntityBellerophon Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001600132-19-000147 · Open the official SEC filing →
Retrieved: 2026-08-19T16:22:44.668338+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001600132/cash-and-restricted-cash/2019-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/91c36c83-d67a-45e6-9fd5-6c13f7685f84

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies